Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value: $588M (99.1% shares, 0.9% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 2,102,280 | $84.07M | 14.3% | — | — | COM | 09627Y109 |
| — | CHEMOCENTRYX INC | 7,990,572 | $58.17M | 9.9% | — | — | COM | 16383L106 |
| CYTK | CYTOKINETICS INC | 4,260,836 | $54.75M | 9.3% | — | — | COM NEW | 23282W605 |
| ANAB | ANAPTYSBIO INC | 1,738,600 | $48.25M | 8.2% | — | — | COM | 032724106 |
| — | CONCERT PHARMACEUTICALS INC | 2,336,609 | $39.86M | 6.8% | — | — | COM | 206022105 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,804,675 | $31.17M | 5.3% | — | — | COM | 23284F105 |
| — | FORWARD PHARMA A/S | 1,387,853 | $29.91M | 5.1% | — | — | SPONSORED ADR | 34986J105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 7,866,108 | $25.41M | 4.3% | — | — | COM | 45665G303 |
| — | ARRAY BIOPHARMA INC | 2,763,086 | $24.7M | 4.2% | — | — | COM | 04269X105 |
| — | CTI BIOPHARMA CORP | 4,479,691 | $18.82M | 3.2% | — | — | COM NEW | 12648L601 |
| — | BIOLINERX LTD SPONSORED | 17,500,000 | $16.81M | 2.9% | — | — | SPONSORED ADR | 09071M106 |
| — | ONCOMED PHARMACEUTICALS INC | 1,760,489 | $16.21M | 2.8% | — | — | COM | 68234X102 |
| — | GLYCOMIMETICS INC | 2,826,282 | $15.35M | 2.6% | — | — | COM | 38000Q102 |
| — | ACHILLION PHARMACEUTICALS INC COM | 3,285,400 | $13.83M | 2.4% | — | — | COM | 00448Q201 |
| — | LOXO ONCOLOGY INC | 320,000 | $13.47M | 2.3% | — | — | COM | 548862101 |
| — | CASCADIAN THERAPEUTICS INC | 3,133,224 | $12.97M | 2.2% | — | — | COM NEW | 14740B606 |
| XENE | XENON PHARMACEUTICALS INC | 2,949,794 | $11.8M | 2.0% | — | — | COM | 98420N105 |
| XOMA | XOMA CORP DEL | 1,502,800 | $10.69M | 1.8% | — | — | COM NEW | 98419J206 |
| FATE | FATE THERAPEUTICS INC | 1,945,245 | $8.851M | 1.5% | — | — | COM | 31189P102 |
| — | IMMUNE DESIGN CORP | 1,233,976 | $8.391M | 1.4% | — | — | COM | 45252L103 |
| — | ARQULE INC | 7,400,128 | $7.844M | 1.3% | — | — | COM | 04269E107 |
| — | SUNESIS PHARMACEUTICALS INC | 1,540,323 | $6.315M | 1.1% | — | — | COM PAR | 867328700 |
| — | OREXIGEN THERAPEUTICS INC | 10,000,000 | $5.475M | 0.9% | — | — | NOTE 2.750% | 686164AB0 |
| — | NIVALIS THERAPEUTICS INC | 1,864,474 | $5.444M | 0.9% | — | — | COM | 65481J109 |
| — | GTX INC DEL | 1,108,433 | $5.387M | 0.9% | — | — | COM NEW | 40052B207 |
| — | PIERIS PHARMACEUTICALS INC | 1,917,033 | $4.984M | 0.8% | — | — | COM | 720795103 |
| — | ANTHERA PHARMACEUTICALS INC | 8,052,073 | $3.426M | 0.6% | — | — | COM NEW | 03674U201 |
| — | OREXIGEN THERAPEUTICS INC | 734,976 | $2.528M | 0.4% | — | — | COM NEW | 686164302 |
| — | PAIN THERAPEUTICS INC | 2,278,552 | $2.035M | 0.3% | — | — | COM | 69562K100 |
| — | REGULUS THERAPEUTICS INC | 623,000 | $1.028M | 0.2% | — | — | COM | 75915K101 |